Understanding antibody-dependent enhancement in dengue: Are afucosylated IgG1s a concern?

Teo, Andrew; Tan, Hao Dong; Loy, Thomas; Chia, Po Ying; Chua, Caroline Lin Lin

Teo, Andrew; Tan, Hao Dong; Loy, Thomas; Chia, Po Ying; Chua, Caroline Lin Lin.

Teo A; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
Tan HD; National Centre for Infectious Diseases, Singapore, Singapore.
Loy T; Department of Medicine, The Doherty Institute, University of Melbourne, Melbourne, Australia.
Chia PY; School of Biosciences, Faculty of Health and Medicine Sciences, Taylor's University, Subang Jaya, Malaysia.
Chua CLL; A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.

PLoS Pathog ; 19(3): e1011223, 2023 03.

Article in English | MEDLINE | ID: covidwho-2291255

Subject(s)

Antibody-Dependent Enhancement; Dengue; Humans; Antibodies, Viral

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antibody-Dependent Enhancement / Dengue Limits: Humans Language: English Journal: PLoS Pathog Year: 2023 Document Type: Article Affiliation country: Journal.ppat.1011223

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google